These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections. Maciá MD; Blanquer D; Togores B; Sauleda J; Pérez JL; Oliver A Antimicrob Agents Chemother; 2005 Aug; 49(8):3382-6. PubMed ID: 16048951 [TBL] [Abstract][Full Text] [Related]
9. Hypermutability in environmental Pseudomonas aeruginosa and in populations causing pulmonary infection in individuals with cystic fibrosis. Kenna DT; Doherty CJ; Foweraker J; Macaskill L; Barcus VA; Govan JRW Microbiology (Reading); 2007 Jun; 153(Pt 6):1852-1859. PubMed ID: 17526842 [TBL] [Abstract][Full Text] [Related]
10. Whole genome sequencing reveals the emergence of a Pseudomonas aeruginosa shared strain sub-lineage among patients treated within a single cystic fibrosis centre. Wee BA; Tai AS; Sherrard LJ; Ben Zakour NL; Hanks KR; Kidd TJ; Ramsay KA; Lamont I; Whiley DM; Bell SC; Beatson SA BMC Genomics; 2018 Aug; 19(1):644. PubMed ID: 30165811 [TBL] [Abstract][Full Text] [Related]
11. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Oliver A; Cantón R; Campo P; Baquero F; Blázquez J Science; 2000 May; 288(5469):1251-4. PubMed ID: 10818002 [TBL] [Abstract][Full Text] [Related]